Did you know that you can buy products from over 140 different suppliers from us?

Bromodeoxyuridine (BrDU) antibody

Details for Product No. ABIN153035
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Antigen
Reactivity
Human
(176), (13), (6), (5), (4), (2), (1), (1)
Host
Sheep
(128), (34), (30), (14), (1)
Clonality
Polyclonal
Conjugate
Un-conjugated
(26), (12), (8), (4), (3), (3), (3), (3), (3), (3), (3), (3), (1), (1), (1)
Application
ELISA, Immunocytochemistry (ICC), Immunofluorescence (IF), Immunohistochemistry (IHC), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunoprecipitation (IP)
(109), (89), (48), (46), (41), (37), (30), (26), (18), (12), (3), (3), (1), (1), (1)
Pubmed 3 references available
Quantity 0.25 mg
Shipping to United States (Change)
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Catalog No. ABIN153035
Contact our Customer Service for availability and price in your country.
Add to Basket

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Immunogen Bromodeoxyuridine (BrdU) coupled to keyhole limpet hemocyanin (KLH).
Specificity BrdU
Purification Protein G purified
Background To measure DNA synthesis or cell proliferation, 5-bromo2’-deoxy-uridine (BrdU) can beincorporated into DNA in place of thymindine. Cells, which have incorporated BrdU intoDNA, can be quickly detected using a monoclonal antibody against BrdU. The binding ofthe antibody is achieved by denaturation of the DNA. This is usually obtained byexposing the cells to acid, or heat. Alternate Names: anti-Bromodeoxyuridine antibody, anti-BUdr antibody.
Research Area Proliferation Markers
Application Notes This BrdU antibody is useful for ICC/IF, IHC-frozen, IHC-paraffin, ELISA, IP and Western blot. .
Recommended dilutions: ELISA 1:100-1:2000, Immunocytochemistry/Immunofluorescence 1:100-1:200, Immunohistochemistry 1:10-1:500, Immunohistochemistry-Frozen 10 µg/mL, Immunohistochemistry-Paraffin 10 µg/mL, Immunoprecipitation 25-100 µg/mL
Protocol Protocol specific for BrdU Antibody Immunohistochemistry protocol for Bromodeoxyuridine (BrdU) Polyclonal AntibodyOriginal antigenic studies performed by Dr David Stollar, Tufts University, Boston, MAABSTRACTNew methods for double and triple colour labeling using monoclonal antibodies to the proliferation-associated markers 5-methly-cytosine, BrdU and Ki67 are described. In order to make incorporated 5-methyl-cytosine or BrdU accessible to most antibodies, mild denaturation of the DNA is needed, and this is usually obtained by exposing the cells to acid or base. This procedure destroys most cellular antigen, including nuclear TdT and Ki
67. In this study, we show that fixation in cold methanol instead of 70 % ethanol for 30 minutes followed by immersion in 7 x 10-3 N NaOH for 10-15 seconds allows BrdU staining with the simultaneous detection of nuclear cytoplasmic and membrane assigns as well as preservation of morphological detail. This method is optimal for detection of nuclear Ki67 and TdT. These reagents, together with antibodies to membrane assigns can be included in triple colour labeling using second layers conjugated to FITC, TRITC and colloidal gold. With these methods it is now possible to characterize the phenotype of dividing cell populations such as precursors in central lymphoid tissues and germinal centre blasts in peripheral lymphoid organs.Reference for tissue staining with anti-BrdUCampana D, Coustan-Smith E, Janossy G, Department of Immunology, Royal Free Hospital School of Medicine, London, UK. J Immunol Methods 107(1):79-88 1988 Feb 24 Double and triple staining methods for studying the proliferative activity of human B and T lymphoid cells AbstractFor best results on unconjugated antibody, use the product at a concentration of 25 to 100 µg/mL. Nearly complete immunoprecipitation was obtained at concentrations of 100 to 500ug/mL. The product has also been tested for utility for staining of bromodeoxyuridine incorporated into DNA of replicating cells. When utilized at a purified concentration of 10 µg/mL, the product is comparable to commercially available monoclonal antibodies commonly used for the same purpose.A key issue is that it is necessary to denature the DNA so as to expose the base to the antibodies. One protocol is: Sachiko Matsuuraa and Kazuo Suzukia Immunohistochemical Analysis of DNA Synthesis During Chronic Stimulation with Isoproterenol in Mouse Submandibular Gland . Journal of Histochemistry and Cytochemistry, Vol. 45, 1137-1146, Immunohistochemistry DNA-synthesizing cells were detected by peroxidase-anti-peroxidase (PAP) immunostaining with anti-BrdU antibodies by the method of Harms et al. 1986 , which was slightly modified as follows: Sections were treated with 2 N HCl at 60C for 15 min and washed in running water for 15 min. After dehydration in an ethanol series, the sections were etched with xylene (15 min, twice). Nuclear proteins, which mask incorporated BrdU, were digested with 0.025 % protease (Type V, Sigma) in PBS at 37C for 10 min, and the sections were then washed with cold PBS three times for 5 min.
Restrictions For Research Use only
Concentration 2.6 mg/mL
Buffer PBS, pH 7.4
Preservative Without preservative
Handling Advice Avoid freeze-thaw cycles
Storage -20 °C
Storage Comment -20 °C.
Supplier Images
anti-Bromodeoxyuridine (BrDU) antibody anti-Bromodeoxyuridine (BrDU) antibody
General Campana, Coustan-Smith, Janossy: "Double and triple staining methods for studying the proliferative activity of human B and T lymphoid cells." in: Journal of immunological methods, Vol. 107, Issue 1, pp. 79-88, 1988 (PubMed).

Morris, Solomon: "BRCA1 : BARD1 induces the formation of conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during DNA replication and repair." in: Human molecular genetics, Vol. 13, Issue 8, pp. 807-17, 2004 (PubMed).

Cooper, Isacson: "Intrastriatal transforming growth factor alpha delivery to a model of Parkinson's disease induces proliferation and migration of endogenous adult neural progenitor cells without differentiation into dopaminergic neurons." in: The Journal of neuroscience : the official journal of the Society for Neuroscience, Vol. 24, Issue 41, pp. 8924-31, 2004 (PubMed).

Validation Images
back to top